Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group
M J Piccart, J A Green, A J Lacave, et al.
Investigational New Drugs
|
August 13, 2005
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study
Emilio Esteban, Joaquin Fra, Yolanda Fernández, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study
H C Wagenaar, S Pecorelli, C Mangioni, et al.
Investigational New Drugs
|
May 14, 2010
Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study
Emilio Esteban Gonzalez, Noemi Villanueva, Joaquin Fra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, et al.
Gynecologic Oncology
|
May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer
H C Wagenaar, N Colombo, I Vergote, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2003
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)
R E N van Rijswijk, J B Vermorken, N Reed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2006
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG
Jacobus Pfisterer, Marie Plante, Ignace Vergote, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 25, 2002
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer
J M Vieitez, M Valladares, M Gracia, et al.
The New England Journal of Medicine
|
September 8, 2010
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer
Ignace Vergote, Claes G Tropé, Frédéric Amant, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group
M J Piccart, J A Green, A J Lacave, et al.
Investigational New Drugs
|
August 13, 2005
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study
Emilio Esteban, Joaquin Fra, Yolanda Fernández, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 31, 2001
Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study
H C Wagenaar, S Pecorelli, C Mangioni, et al.
Investigational New Drugs
|
May 14, 2010
Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study
Emilio Esteban Gonzalez, Noemi Villanueva, Joaquin Fra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, et al.
Gynecologic Oncology
|
May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer
H C Wagenaar, N Colombo, I Vergote, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2003
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)
R E N van Rijswijk, J B Vermorken, N Reed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2006
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG
Jacobus Pfisterer, Marie Plante, Ignace Vergote, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 25, 2002
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer
J M Vieitez, M Valladares, M Gracia, et al.
The New England Journal of Medicine
|
September 8, 2010
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer
Ignace Vergote, Claes G Tropé, Frédéric Amant, et al.
Page
of 7